Why Whole-Genome Testing Hurts More Than it Helps
By H. Gilbert Welch and Wylie Burke,
Los Angeles Times
| 04. 27. 2015
Untitled Document
President Obama proposes to plunk down $215 million on "precision medicine," and the National Institutes of Health and its National Cancer Institute will spend it by sequencing the whole genome of a million or more Americans.
Is whole-genome testing the path to health? The short answer is no.
The main problem with the proposal is that the research is bound to produce more noise than signal. The issue isn't genetics but "big" data. The basic idea of precision medicine is to look for patterns in the genome that seem to travel with problems we all care about: diabetes, heart disease, cancer and dementia. But there are a lot of possible patterns to look for.
Imagine there were only 10 data points in a person's genome and that each point could only take on one of two values: red or green. The first could be red or green, the second red or green and so forth. The number of possible patterns that could emerge from those 10 data points is 2 to the 10th power — 1,024 patterns...
Related Articles
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Rowan Walrath and Laurel Oldach, Chemical & Engineering News | 03.04.2026
Washington, DC—At a press conference held at the US Department of Health and Human Services headquarters on Feb. 23, two doctors from the University of Pennsylvania and Children’s Hospital of Philadelphia spoke about their hope for the future of...
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
